Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion type Assertion NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_head.
- NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_provenance.
- NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion evidence source_evidence_literature NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_provenance.
- NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion SIO_000772 17577920 NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_provenance.
- NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion wasDerivedFrom befree-20150227 NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_provenance.
- NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion wasGeneratedBy ECO_0000203 NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_provenance.